Researchers at City of Hope combine oncolytic virus with a CAR-T to eradicate solid tumors in mice
A new combination of existing cancer treatments is showing early signs of potentially cracking open a new approach to treating solid tumors.
In preclinical research published by City of Hope, a California-based non-profit, scientists effectively blended CAR-T therapy with an oncolytic virus to eradicate solid tumors in mice. The virus is genetically engineered to enter the tumors and force them to express the CD19 protein, allowing the CAR-T cells to attack.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.